<DOC>
	<DOCNO>NCT02873208</DOCNO>
	<brief_summary>The primary objective study evaluate long-term safety tolerability ALKS 3831 subject schizophrenia .</brief_summary>
	<brief_title>A Phase 3 , Long-term Safety Tolerability Study ALKS 3831 Adults With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Agrees use acceptable method contraception duration study Subject complete 24week treatment period antecedent study , ALK3831A303 , within 7 day Additional criterion may apply Subject currently take medication contraindicate olanzapine use exhibit druginteraction potential olanzapine Subject positive test drug abuse study entry Subject pregnant , plan become pregnant , breastfeed study Additional criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Alkermes</keyword>
	<keyword>ALKS 3831</keyword>
	<keyword>Samidorphan</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Safety</keyword>
</DOC>